Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
12/2008
12/31/2008EP2007774A1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
12/31/2008EP2007773A1 Thiazolyl dihydro-indazoles
12/31/2008EP2007772A1 Thiazolyl-dihydroquinazolines
12/31/2008EP2007770A1 Imidazo compounds
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007725A2 Non-peptidic renin inhibitors nitroderivatives
12/31/2008EP2007382A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
12/31/2008EP1543013B1 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one monosodium salt as CXCR2 antagonist
12/31/2008EP1542974B1 5-[((2,3-difluorophenyl)methyl)thio]-7-{[(1S,2S)-2-hydroxy-1-(hydroxymethyl)propyl]amino}thiazolo[4,5-d]pyrimidin-2(3H)-one as CXCR2 antagonist
12/31/2008CN101335331A 有机半导体材料和半导体器件 Organic semiconductor materials and semiconductor devices
12/31/2008CN100447145C 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof
12/31/2008CA2692085A1 Fused thiazole derivatives as kinase inhibitors
12/30/2008US7470714 GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470691 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/25/2008US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents
12/25/2008US20080318998 Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
12/25/2008US20080318981 Novel Compounds 480
12/24/2008WO2008156869A2 Sirtuin modulating thiazolopyridine compounds
12/24/2008WO2008156866A1 Sirtuin modulating imidazothiazole compounds
12/24/2008WO2008156159A1 Process for production of diamine derivative
12/24/2008EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors
12/24/2008EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/24/2008EP2004647A1 Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones
12/24/2008EP2004641A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
12/24/2008EP1147115B3 Tricyclic benzodiazepines as vasopressin receptor antagonists
12/24/2008CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445274C 2,1,3-benzothiadiazoles for use as electronic active components
12/24/2008CA2692099A1 Sirtuin modulating imidazothiazole compounds
12/24/2008CA2691733A1 Sirtuin modulating compounds
12/23/2008US7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitors
12/23/2008US7468376 Pyrazolopyridine derivates
12/18/2008WO2008152603A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008WO2008152390A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
12/18/2008WO2008151969A1 Piperazine and [1,4] diazepan derivatives as nk antagonists
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312256 Organic Compounds
12/18/2008US20080312216 Piperazine and [1,4]diazepan derivatives as nk antagonists
12/18/2008US20080311644 Amino Methylated 2-Pyridinones
12/18/2008CA2692050A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
12/18/2008CA2690299A1 Piperazine and [1,4] diazepan derivatives as nk antagonists
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/17/2008EP2001893A2 Thiadiazole compounds and their use in phototherapy
12/17/2008EP2001892A2 Imidazolothiazole compounds for the treatment of disease
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1443822B1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008CN101323609A Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide
12/17/2008CN100443483C Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses
12/16/2008US7465743 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
12/16/2008US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative
12/16/2008CA2399377C New positive allosteric ampa receptor modulators (paarm), processes for preparing them and their use as pharmaceutical compositions
12/11/2008WO2008150015A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
12/11/2008WO2007096618A3 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use
12/11/2008WO2007092364A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/11/2008US20080306262 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306042 Triazole Derivatives
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008CA2688621A1 Macrocycles and their uses
12/10/2008CN100441578C Imidazole ring-containing compound and organic electroluminescence display device
12/10/2008CN100441185C 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
12/09/2008US7462721 Aza-quinolinol phosphonate integrase inhibitor compounds
12/09/2008US7462640 e.g. 5-Chloro-3-methyl-N-[1-[2-(pyrrolidin-1-yl)ethyl-1H-indol-6-yl]-benzo[b]thiophene-2-sulfonamide; serotonin receptor modulator; anxiolytic agent, antidepressant; nervous and gastrointestinal disorders, antidiabetic agent; bipolar disorders, cognitive memory disorders, neurodegenerative disorders
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462611 Pyrro[1,2-b]pyridazinone compounds
12/09/2008CA2382919C Bicyclic imidazo-3-yl-amine derivatives
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008111018A3 Process for the preparation of crystals of prulifloxacin
12/04/2008WO2008039641A3 Substituted phenylether-thienopyridone compounds with antibacterial activity
12/04/2008WO2007075749A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/03/2008EP1996596A2 Substituted imidazo(2,1-b)thiazole compounds and their use for producing drugs
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators
12/02/2008US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
12/02/2008US7459451 Pyrazolopyridine derivatives
12/02/2008US7459450 metabolic and eating disorders, symptoms of hepatitis C, pain, sexual dysfunction, congestive heart failure, cerebral hemorrhage, anxiety, depression, epileptic seizures, sleep disorders, migraine and allergic rhinitis.
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
11/2008
11/27/2008WO2008144360A1 Novel compounds as cannabinoid receptor ligands
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008141455A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008WO2007143468A3 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293744 Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
11/27/2008US20080293689 Compounds with Atypical Antipsychotic Activity
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008CA2688823A1 Heterocyclic kinase modulators
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2687338A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 152